California device startup treating abnormal uterine bleeding raises $20M

California device startup and women’s health firm Minerva Surgical has recently raised $20 million, according to a regulatory filing.

The Cupertino-based company has developed an endometrial ablation system utilizing RF Argon Plasma Energy contained in a balloon to treat heavy menstrual bleeding.

Based on a search of the U.S. Securities and Exchange Commission’s Edgar database, the company has been steadily raising money since 2008 and has raised more than $55 million. David M. Clapper, a 16-year veteran of Johnson & Johnson, is Minerva Surgical’s CEO.


Venture capital firm New Enterprise Associates and Vivo Ventures are investors in the company, although it is not known whether they invested in this round of funding.

[Photo Credit: Pile of Money from Big Stock Photo]



We’re bringing active investors and corporate development execs together with promising startups at MedCity News INVEST. Join us April 12-13, 2016, in Chicago for the premier national investing conference based in the Midwest.

1 comment